The interest in Obducat's nanolithography solutions is significantly increasing among customers within the biotechnology and medical industry. Obducat's successful implementation and participation in a project focused on transdermal drug delivery has demonstrated the benefits and extensive utilization of our technologies. A more efficient health care system requires the development of new solutions, with improved accuracy, for analytics and for diagnostic applications. Devices that can enable a move of the Point-of-Care from hospitals to them patients themselves are highly prioritized. Already today there are simpler systems available that monitors specific health parameters and they are normally integrated with various type of mobile devices. In order to further develop these systems and to enhance their inherent capabilities and enable cost reductions in the health care, more intelligent systems need to realized and that is where NIL is anticipated to play a key role.
